Chemotherapy for peritoneal dissemination in gastric cancer under ureteral catheterization

The treatment of peritoneal dissemination of gastric cancer is mainly chemotherapy, but it use is often limited by ileus, hydronephrosis and jaundice. We employed a ureteral catheter for 6 patients with hydronephrosis due to peritoneal dissemination. Chemotherapy (CDDP + ADM + 5-FU or MTX + 5-FU) wa...

Full description

Saved in:
Bibliographic Details
Published inGan to kagaku ryoho Vol. 23; no. 14; p. 1951
Main Authors Kubo, Y, Kurita, A, Saeki, T, Yokoyama, N, Tanada, M, Takiyama, W, Saeki, H, Takashima, S
Format Journal Article
LanguageJapanese
Published Japan 01.12.1996
Subjects
Adenocarcinoma - drug therapy
Adenocarcinoma - secondary
Aged
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Cisplatin - administration & dosage
Doxorubicin - administration & dosage
Female
Fluorouracil - administration & dosage
Humans
Hydronephrosis - complications
Hydronephrosis - therapy
Male
Middle Aged
Peritoneal Neoplasms - drug therapy
Peritoneal Neoplasms - secondary
Stomach Neoplasms - drug therapy
Stomach Neoplasms - pathology
Urinary Catheterization
Online AccessGet more information

Cover

More Information
Summary:The treatment of peritoneal dissemination of gastric cancer is mainly chemotherapy, but it use is often limited by ileus, hydronephrosis and jaundice. We employed a ureteral catheter for 6 patients with hydronephrosis due to peritoneal dissemination. Chemotherapy (CDDP + ADM + 5-FU or MTX + 5-FU) was administered in 5 patients. After ureteral catheterization, renal function was kept within normal ranges, so chemotherapy was performed safely. One of five patients became CR and the effect of the treatment was satisfactory (PR: 1, NC: 2). Thus, chemotherapy after ureteral catheterization may be effective for patients with peritoneal dissemination and hydronephrosis.
ISSN:0385-0684